KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Notes Payables: 2010-2012

Historic Notes Payables for TherapeuticsMD (TXMD) over the last 3 years, with Dec 2012 value amounting to $3.1 million.

  • TherapeuticsMD's Notes Payables rose 44.28% to $3.1 million in Q4 2012 from the same period last year, while for Dec 2012 it was $3.1 million, marking a year-over-year increase of 44.28%. This contributed to the annual value of $3.1 million for FY2012, which is 44.28% up from last year.
  • Latest data reveals that TherapeuticsMD reported Notes Payables of $3.1 million as of FY2012, which was up 44.28% from $2.1 million recorded in FY2011.
  • Over the past 5 years, TherapeuticsMD's Notes Payables peaked at $3.1 million during FY2012, and registered a low of $543,531 during FY2010.
  • In the last 3 years, TherapeuticsMD's Notes Payables had a median value of $2.1 million in 2011 and averaged $1.9 million.
  • Data for TherapeuticsMD's Notes Payables shows a peak YoY soared of 295.56% (in 2011) over the last 5 years.
  • Yearly analysis of 3 years shows TherapeuticsMD's Notes Payables stood at $543,531 in 2010, then skyrocketed by 295.56% to $2.1 million in 2011, then spiked by 44.28% to $3.1 million in 2012.